Skip to main content
Quest Diagnostics

Correlation of Serotonin Release Assay Positivity With ELISA OD Value and Impact on the Management of Patients Suspected With HIT

Correlation of Serotonin Release Assay Positivity With ELISA OD Value and Impact on the Management of Patients Suspected With HIT

Authors: Ianosi-Irimie M, Aljuboori O, Edmonston TB, Worfolk LA, Bi C, Tong C, Noh LJ, Espinoza A, Sahud MA, Dlott JS, Racke FK, Wong ECC

Citation: Int J Lab Hematol. 2026 Jun 18. doi: 10.1111/ijlh.70176. Online ahead of print.

Specialties: Coagulation, Hematology

Related content

Conference Presentation
Outcomes of Heparin-Induced Thrombocytopenia (HIT) Treated with Therapeutic Plasma Exchange: An Updated Report of the ASFA HIT Registry
Test FAQ
Anti PF4 and Serotonin Release Assay SRA for Diagnosing Heparin induced Thrombocytopenia Thrombosis HIT HITT
Test FAQ
Prothrombin Time With INR

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.